BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37019472)

  • 1. Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats.
    Kamble SH; Obeng S; León F; Restrepo LF; King TI; Berthold EC; Kanumuri SRR; Gamez-Jimenez LR; Pallares VLC; Patel A; Ho NP; Hampson A; McCurdy CR; McMahon LR; Wilkerson JL; Sharma A; Hiranita T
    J Pharmacol Exp Ther; 2023 Jun; 385(3):180-192. PubMed ID: 37019472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactive Effects of
    Obeng S; Leon F; Patel A; Zuarth Gonzalez JD; Chaves Da Silva L; Restrepo LF; Gamez-Jimenez LR; Ho NP; Guerrero Calvache MP; Pallares VLC; Helmes JA; Shiomitsu SK; Soto PL; McCurdy CR; McMahon LR; Wilkerson JL; Hiranita T
    J Pharmacol Exp Ther; 2022 Dec; 383(3):182-198. PubMed ID: 36153006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for
    Obeng S; Wilkerson JL; León F; Reeves ME; Restrepo LF; Gamez-Jimenez LR; Patel A; Pennington AE; Taylor VA; Ho NP; Braun T; Fortner JD; Crowley ML; Williamson MR; Pallares VLC; Mottinelli M; Lopera-Londoño C; McCurdy CR; McMahon LR; Hiranita T
    J Pharmacol Exp Ther; 2021 Mar; 376(3):410-427. PubMed ID: 33384303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the rewarding effects of mitragynine and 7-hydroxymitragynine in an intracranial self-stimulation procedure in male and female rats.
    Behnood-Rod A; Chellian R; Wilson R; Hiranita T; Sharma A; Leon F; McCurdy CR; McMahon LR; Bruijnzeel AW
    Drug Alcohol Depend; 2020 Oct; 215():108235. PubMed ID: 32889450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolite profiling and identification of enzymes responsible for the metabolism of mitragynine, the major alkaloid of
    Kamble SH; Sharma A; King TI; León F; McCurdy CR; Avery BA
    Xenobiotica; 2019 Nov; 49(11):1279-1288. PubMed ID: 30547698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations.
    Tanna RS; Tian DD; Cech NB; Oberlies NH; Rettie AE; Thummel KE; Paine MF
    J Pharmacol Exp Ther; 2021 Jan; 376(1):64-73. PubMed ID: 33093187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions.
    Todd DA; Kellogg JJ; Wallace ED; Khin M; Flores-Bocanegra L; Tanna RS; McIntosh S; Raja HA; Graf TN; Hemby SE; Paine MF; Oberlies NH; Cech NB
    Sci Rep; 2020 Nov; 10(1):19158. PubMed ID: 33154449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo pharmacology of kratom.
    Hiranita T; Obeng S; Sharma A; Wilkerson JL; McCurdy CR; McMahon LR
    Adv Pharmacol; 2022; 93():35-76. PubMed ID: 35341571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Lack of Contribution of 7-Hydroxymitragynine to the Antinociceptive Effects of Mitragynine in Mice: A Pharmacokinetic and Pharmacodynamic Study.
    Berthold EC; Kamble SH; Raju KS; Kuntz MA; Senetra AS; Mottinelli M; León F; Restrepo LF; Patel A; Ho NP; Hiranita T; Sharma A; McMahon LR; McCurdy CR
    Drug Metab Dispos; 2022 Feb; 50(2):158-167. PubMed ID: 34759012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of mitragynine and morphine on schedule-controlled responding and antinociception in rats.
    Hiranita T; Leon F; Felix JS; Restrepo LF; Reeves ME; Pennington AE; Obeng S; Avery BA; McCurdy CR; McMahon LR; Wilkerson JL
    Psychopharmacology (Berl); 2019 Sep; 236(9):2725-2734. PubMed ID: 31098655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Mitragynine and 7-Hydroxymitragynine Pharmacokinetics after Single and Multiple Daily Doses of Oral Encapsulated Dried Kratom Leaf Powder.
    Huestis MA; Brett MA; Bothmer J; Atallah R
    Molecules; 2024 Feb; 29(5):. PubMed ID: 38474495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine.
    Hemby SE; McIntosh S; Leon F; Cutler SJ; McCurdy CR
    Addict Biol; 2019 Sep; 24(5):874-885. PubMed ID: 29949228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Pharmacokinetics in Beagle Dogs of the Mitragynine Metabolite, 7-Hydroxymitragynine.
    Maxwell EA; King TI; Kamble SH; Raju KSR; Berthold EC; León F; Hampson A; McMahon LR; McCurdy CR; Sharma A
    Eur J Drug Metab Pharmacokinet; 2021 May; 46(3):459-463. PubMed ID: 33847897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus properties of mitragynine (kratom) in rats.
    Harun N; Hassan Z; Navaratnam V; Mansor SM; Shoaib M
    Psychopharmacology (Berl); 2015 Jul; 232(13):2227-38. PubMed ID: 25616583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of in vitro absorption, distribution, metabolism, and excretion (ADME) properties of mitragynine, 7-hydroxymitragynine, and mitraphylline.
    Manda VK; Avula B; Ali Z; Khan IA; Walker LA; Khan SI
    Planta Med; 2014 May; 80(7):568-76. PubMed ID: 24841968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinociceptive effect of 7-hydroxymitragynine in mice: Discovery of an orally active opioid analgesic from the Thai medicinal herb Mitragyna speciosa.
    Matsumoto K; Horie S; Ishikawa H; Takayama H; Aimi N; Ponglux D; Watanabe K
    Life Sci; 2004 Mar; 74(17):2143-55. PubMed ID: 14969718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 7-Hydroxymitragynine Is an Active Metabolite of Mitragynine and a Key Mediator of Its Analgesic Effects.
    Kruegel AC; Uprety R; Grinnell SG; Langreck C; Pekarskaya EA; Le Rouzic V; Ansonoff M; Gassaway MM; Pintar JE; Pasternak GW; Javitch JA; Majumdar S; Sames D
    ACS Cent Sci; 2019 Jun; 5(6):992-1001. PubMed ID: 31263758
    [No Abstract]   [Full Text] [Related]  

  • 18. The respiratory depressant effects of mitragynine are limited by its conversion to 7-OH mitragynine.
    Hill R; Kruegel AC; Javitch JA; Lane JR; Canals M
    Br J Pharmacol; 2022 Jul; 179(14):3875-3885. PubMed ID: 35297034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative Metabolism as a Modulator of Kratom's Biological Actions.
    Chakraborty S; Uprety R; Slocum ST; Irie T; Le Rouzic V; Li X; Wilson LL; Scouller B; Alder AF; Kruegel AC; Ansonoff M; Varadi A; Eans SO; Hunkele A; Allaoa A; Kalra S; Xu J; Pan YX; Pintar J; Kivell BM; Pasternak GW; Cameron MD; McLaughlin JP; Sames D; Majumdar S
    J Med Chem; 2021 Nov; 64(22):16553-16572. PubMed ID: 34783240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP450-Mediated Metabolism of Mitragynine and Investigation of Metabolites in Human Urine.
    Basiliere S; Kerrigan S
    J Anal Toxicol; 2020 May; 44(4):301-313. PubMed ID: 32008041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.